These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16296724)

  • 41. Long-circulating vectors for the systemic delivery of genes.
    Fenske DB; MacLachlan I; Cullis PR
    Curr Opin Mol Ther; 2001 Apr; 3(2):153-8. PubMed ID: 11338928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current prospects for gene therapy of cystic fibrosis.
    Ziady AG; Davis PB
    Curr Opin Pharmacol; 2006 Oct; 6(5):515-21. PubMed ID: 16890018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The combination of stabilized plasmid lipid particles and lipid nanoparticle encapsulated CpG containing oligodeoxynucleotides as a systemic genetic vaccine.
    Wilson KD; de Jong SD; Kazem M; Lall R; Hope MJ; Cullis PR; Tam YK
    J Gene Med; 2009 Jan; 11(1):14-25. PubMed ID: 19003796
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety of viral vectors for neurological gene therapies.
    Maguire-Zeiss KA; Federoff HJ
    Curr Opin Mol Ther; 2004 Oct; 6(5):473-81. PubMed ID: 15537048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The assembly of a short linear natural cytosine-phosphate-guanine DNA into dendritic structures and its effect on immunostimulatory activity.
    Rattanakiat S; Nishikawa M; Funabashi H; Luo D; Takakura Y
    Biomaterials; 2009 Oct; 30(29):5701-6. PubMed ID: 19604576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intracellular routing of plasmid DNA during non-viral gene transfer.
    Lechardeur D; Verkman AS; Lukacs GL
    Adv Drug Deliv Rev; 2005 Apr; 57(5):755-67. PubMed ID: 15757759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extrachromosomal plasmid vectors for gene therapy.
    Stoll SM; Calos MP
    Curr Opin Mol Ther; 2002 Aug; 4(4):299-305. PubMed ID: 12222867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma.
    Wu A; Oh S; Ericson K; Demorest ZL; Vengco I; Gharagozlou S; Chen W; Low WC; Ohlfest JR
    Cancer Gene Ther; 2007 Jun; 14(6):550-60. PubMed ID: 17415381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bacterial magnetic particles (BMPs)-PEI as a novel and efficient non-viral gene delivery system.
    Xiang L; Bin W; Huali J; Wei J; Jiesheng T; Feng G; Ying L
    J Gene Med; 2007 Aug; 9(8):679-90. PubMed ID: 17605136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting the heart with gene therapy-optimized gene delivery methods.
    Müller OJ; Katus HA; Bekeredjian R
    Cardiovasc Res; 2007 Feb; 73(3):453-62. PubMed ID: 17097076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides.
    Wilson HL; Dar A; Napper SK; Marianela Lopez A; Babiuk LA; Mutwiri GK
    Int Rev Immunol; 2006; 25(3-4):183-213. PubMed ID: 16818371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Production of plasmid DNA for pharmaceutical use.
    Voss C
    Biotechnol Annu Rev; 2007; 13():201-22. PubMed ID: 17875478
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Construction and expression analysis of micro-linear vector as a new general gene therapy vector].
    Wang H; Li X; He Y; Xie B; Tang W; Du J
    Sheng Wu Gong Cheng Xue Bao; 2008 Aug; 24(8):1333-9. PubMed ID: 18998532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Direct immunologic activities of CpG DNA and implications for gene therapy.
    Krieg AM
    J Gene Med; 1999; 1(1):56-63. PubMed ID: 10738585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TLR9 and the recognition of self and non-self nucleic acids.
    Lamphier MS; Sirois CM; Verma A; Golenbock DT; Latz E
    Ann N Y Acad Sci; 2006 Oct; 1082():31-43. PubMed ID: 17145922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of gene expression efficiency and innate immune response induced by Ad vector and lipoplex.
    Sakurai H; Sakurai F; Kawabata K; Sasaki T; Koizumi N; Huang H; Tashiro K; Kurachi S; Nakagawa S; Mizuguchi H
    J Control Release; 2007 Feb; 117(3):430-7. PubMed ID: 17239467
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Immunostimulatory properties of CpG sequences in bacterial DNA].
    Smolarczyk R; Szala S
    Postepy Biochem; 2004; 50(4):296-303. PubMed ID: 15957525
    [No Abstract]   [Full Text] [Related]  

  • 58. Current prospects for mRNA gene delivery.
    Yamamoto A; Kormann M; Rosenecker J; Rudolph C
    Eur J Pharm Biopharm; 2009 Mar; 71(3):484-9. PubMed ID: 18948192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancement of immunity and resistance in mice by pig IL-6 gene and CpG motifs encapsulated in chitosan nanoparticle.
    Chen Q; Zhao ZZ; Peng R; Wang YY; Xie Z; Wang ZZ; Li JL; Lv XB; Wu KY; Fu ML; Wang HN; Gao R
    Biotechnol J; 2008 Feb; 3(2):264-73. PubMed ID: 18213660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How not to be seen: immune-evasion strategies in gene therapy.
    Zaldumbide A; Hoeben RC
    Gene Ther; 2008 Feb; 15(4):239-46. PubMed ID: 18046427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.